Novo Shutters Cell Therapy Unit, Ending Work on Potential Type 1 Diabetes 'cure'
Posted3 months agoActive3 months ago
fiercebiotech.comOtherstory
skepticalnegative
Debate
0/100
BiotechType 1 DiabetesCell Therapy
Key topics
Biotech
Type 1 Diabetes
Cell Therapy
Novo Nordisk is shutting down its cell therapy unit, abandoning a potential 'cure' for Type 1 diabetes, sparking concerns about the challenges and risks associated with such research.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
2m
Peak period
1
0-1h
Avg / period
1
Key moments
- 01Story posted
Oct 14, 2025 at 9:40 AM EDT
3 months ago
Step 01 - 02First comment
Oct 14, 2025 at 9:42 AM EDT
2m after posting
Step 02 - 03Peak activity
1 comments in 0-1h
Hottest window of the conversation
Step 03 - 04Latest activity
Oct 14, 2025 at 9:42 AM EDT
3 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
ID: 45579919Type: storyLast synced: 11/17/2025, 10:06:23 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.
Also part of a larger trend of boiopharma pulling away from cell therapy development. The science seems to work but too expensive to operationalize and manufacture just to customize bespoke treatment for every patient, not sustainable financially.